Drug Resistant Pneumonia Treatment Navigation


Drug Resistant Pneumonia Treatment

|

Partners
Tell A Friend about us
Holistic Addiction Treatment |
Alcohol Treatment Grand Forks Nd |
Drug Treatment Kitchener |
Drug Rehab Online |
Drug Treatment Wichita Ks |
Drug Rehab Centers For Veterans |
Drug Rehab Napa |
Drug Treatment Squamous Cell Carcinoma |
Drug Rehab Elizabethtown Ky |
Treatment Facility |
Johnson Chemical Dependency Center |
Drug Treatment Tetanus |
Outpatient Alcohol Programs |
Drug Addiction Rehabs |
Inpatient Substance Abuse Treatment |

List of Drug-Alcohol-Treatment Articles

Drug Resistant Pneumonia Treatment Best Seller



Best Drug Resistant Pneumonia Treatment Products

Social bookmarking
You like it? Share it!
socialize it


Main Drug Resistant Pneumonia Treatment Sponsors


Drug Resistant Pneumonia Treatment

 

Latest Drug Resistant Pneumonia Treatment Link Added

Top 5 Drug and Alcohol Treatment Pages

1. Drug Rehab
2. Drug Alcohol
3. Drug Treatment
4. Drug Addiction
5. Alcohol Treatment




Submit your link on Drug Resistant Pneumonia Treatment!


Welcome to Drug and Alcohol Treatment


 

Drug Resistant Pneumonia Treatment Article

Thumbnail example

This is a selection made from among articles on Drug Resistant Pneumonia Treatment. For a permanent link to this article, or to bookmark it for future reading, click here.

Drug Addiction Statistics

from:


Some people don’t like being quoted statistics. But when we speak of statistics on drug addiction, the numbers are actually important. These numbers can help us identify problem areas with drug addictions and help us better understand what exactly is going on with drug addiction in the country.

For example, marijuana is the most commonly used illicit drug in the United States according to a 2005 survey. Over seventy-six percent of the population reported using marijuana in that year’s time.

An estimated 15.9 million Americans aged twelve or older reported using illicit drug in the month prior to the 2005 survey. That statistic represents 7.1 percent of the population 12 or older. This is an increase of almost 8 percent from the previous year.

Drug addiction statistics can be a little bit scary as well. Consider that in 2003, there were nearly 20,000 deaths directly attributed to drug use both legal and illegal. Of those deaths, about 3 percent were to people 21 years of age and under.

In the year 2001 alone, use of the club drug Ecstasy increased by 58 percent from the previous year. This statistic was calculated by the amount of people who were admitted to a hospital emergency room with Ecstasy overdoses.

Statistics on rehabilitation center admissions also paint a sad picture of drug addiction. In 2006, there were over 175,000 people who checked themselves into a rehab facility. It is estimated that 5 percent of those people returned to using drugs after they were released.

Methamphetamine use is on the rise as well. In 2006, a whopping 15 percent of the population reported using meth as their primary illicit drug. This can be attributed to the fact that meth is easy to make with common household items and produces a significant high for the user that cannot be obtained by using any other drug.

Perhaps the scariest statistics on drug addiction are the ones that involve our youth. A significant percentage of young people report having been introduced to one type of drug or another on a regular basis by the age of 13. Nearly fifty percent of those children will try drugs by that age, and 20 percent will become addicted before graduating from high school.

It can be a big, bad world out there – for adults and children alike. We may sincerely want to bury our heads in the sand when it comes to drug abuse and addiction, but we can’t. When presented with statistics on drug addiction, there’s really no way we can ignore the fact that there’s a problem in this country – a serious problem – with drugs.



Drug Resistant Pneumonia Treatment Specific links

Drug Resistant Pneumonia Treatment News

Basilea participates in public-private collaboration to tackle antibiotic ... - Healthcare Global (press release)


Basilea participates in public-private collaboration to tackle antibiotic ...
Healthcare Global (press release)
Antibiotic resistance is increasingly becoming a worldwide health threat. Many of the medical advances in recent years, such as chemotherapy for cancer treatment and organ transplantation, depend on effective antibiotics. Despite this need and the ...

and more »

Read more...


Short Course of Drug Fails in Vent-Associated Pneumonia - MedPage Today


Short Course of Drug Fails in Vent-Associated Pneumonia
MedPage Today
Doripenem is not approved in the US to treat ventilator-associated pneumonia – although it is in many other countries – but only for serious bacterial infections of the urinary tract, kidney, and abdomen. It is usually given in 500-mg, 1-hour infusions ...

Read more...


A pill for every ill is dangerous prescription - Pittsburgh Tribune-Review


A pill for every ill is dangerous prescription
Pittsburgh Tribune-Review
It is not surprising, then, that the relentless overuse of antibiotics is blamed for a surge in deadly, drug-resistant strains of bacteria. Yet many people choose to ignore that and instead clog urgent-care centers, doctors' offices and sometimes ...

and more »

Read more...


Blood test to detect bacterial pneumonia is tested in Akron; may reduce ... - Plain Dealer (blog)


Plain Dealer (blog)

Blood test to detect bacterial pneumonia is tested in Akron; may reduce ...
Plain Dealer (blog)
About half of all pneumonia cases are caused by viruses, which aren't treatable with antibiotics. Such treatment on viral pneumonia would only increase the cost of care and contribute to the problem of antibiotic resistance and opportunistic infections ...

and more »

Read more...


Antibiotic Overuse May Increase Superbug Evolution Rate - Wired News


Wired News

Antibiotic Overuse May Increase Superbug Evolution Rate
Wired News
Subjected to environments that favor drug-tolerating individuals, bacteria have evolved in predictable ways, and antibiotic resistance has reached near-crisis proportions. Historical scourges like tuberculosis and pneumonia have returned with a ...

and more »

Read more...


Medical Treatments From 200 Miles Up - Inside Science News Service


Medical Treatments From 200 Miles Up
Inside Science News Service
It can provide better drug delivery and new medical treatments for solid tumors and resistant infections. Those encapsulated drugs could be directly injected into a tumor and would go to work destroying the cancer from the inside out.

and more »

Read more...


Drug-Defying Germs From India Speed Post-Antibiotic Era - Bloomberg


Bloomberg

Drug-Defying Germs From India Speed Post-Antibiotic Era
Bloomberg
Medical Tourism Poor hygiene has spread resistant germs into India's drains, sewers and drinking water, putting millions at risk of drug-defying infections. Antibiotic residues from drug manufacturing, livestock treatment and medical waste have entered ...

and more »

Read more...


Popular Antibiotic May Raise Risk of Sudden Death - New York Times


RedOrbit

Popular Antibiotic May Raise Risk of Sudden Death
New York Times
Azithromycin is used to treat bacterial infections, including bronchitis, pneumonia, sore throats and earaches. It is familiar to many people as the “Z-Pak,” to be taken for five days, and part of its appeal is its convenience; many other antibiotics ...
Popular Antibiotic May Be Responsible For Sudden Cardiac DeathRedOrbit

all 163 news articles »

Read more...


Kenta Biotech obtains EU Orphan Drug Status for antibody against pneumonia - Great Reporter


Kenta Biotech obtains EU Orphan Drug Status for antibody against pneumonia
Great Reporter
Kenta Biotech announced today that the European Commission has granted 'Orphan Drug' status to Kenta Biotech's product KBSA301 for the treatment of severe pneumonia caused by Staphylococcus aureus (S. aureus). In addition to KBSA301, Kenta Biotech's ...

and more »

Read more...


Paratek Appoints Dennis Molnar as CEO and Evan Loh as Chair - Private Equity Hub (press release)


Paratek Appoints Dennis Molnar as CEO and Evan Loh as Chair
Private Equity Hub (press release)
Dr. Loh stated, “The need for new treatments for antibiotic resistance has never been greater, and many in the clinical community see an unfolding crisis that will require continued commitments to innovation, drug development expertise and close ...

and more »

Read more...